D
Daniel Frey
Researcher at Paul Scherrer Institute
Publications - 19
Citations - 1004
Daniel Frey is an academic researcher from Paul Scherrer Institute. The author has contributed to research in topics: Microtubule & Tubulin. The author has an hindex of 12, co-authored 19 publications receiving 856 citations.
Papers
More filters
Journal ArticleDOI
Structure-function relationship of CAP-Gly domains
Anke Weisbrich,Srinivas Honnappa,Rolf Jaussi,Oksana Okhrimenko,Daniel Frey,Ilian Jelesarov,Anna Akhmanova,Michel O. Steinmetz +7 more
TL;DR: The findings define the molecular basis of CAP-Gly domain function, including the tubulin detyrosination-tyrosination cycle, and establish fundamental roles for the interaction between CAP-gly proteins and C-terminal EEY/F sequence motifs in regulating complex and dynamic cellular processes.
Journal ArticleDOI
Structural basis of tubulin tyrosination by tubulin tyrosine ligase
Andrea E. Prota,Maria M. Magiera,Marijn Kuijpers,Katja Bargsten,Daniel Frey,Mara M. Wieser,Rolf Jaussi,Casper C. Hoogenraad,Richard A. Kammerer,Carsten Janke,Michel O. Steinmetz +10 more
TL;DR: Structural analysis of a complex of tubulin and tubulin tyrosine ligase (TTL) reveals insights into TTL’s enzymatic mechanism, how it discriminates between α- and β-tubulin, and its possible evolutionary origin.
Journal ArticleDOI
Structural basis for recognition of synaptic vesicle protein 2C by botulinum neurotoxin A
Roger Benoit,Daniel Frey,Manuel Hilbert,Josta T. Kevenaar,Mara M. Wieser,Christian U. Stirnimann,David McMillan,Tom Ceska,Florence Lebon,Rolf Jaussi,Michel O. Steinmetz,Gebhard F. X. Schertler,Casper C. Hoogenraad,Guido Capitani,Richard A. Kammerer +14 more
TL;DR: The high-resolution crystal structure of the BoNT/A receptor-binding domain (BoNT/ a-RBD) in complex with the SV2C luminal domain (SV2C-LD) is determined, providing a strong platform for the development of novel antitoxin agents and for the rational design of Bo NT/A variants with improved therapeutic properties.
Journal ArticleDOI
Automated unrestricted multigene recombineering for multiprotein complex production
Christoph Bieniossek,Christoph Bieniossek,Yan Nie,Yan Nie,Daniel Frey,Natacha Olieric,Christiane Schaffitzel,Ian Collinson,Christophe Romier,Philipp Berger,Timothy J. Richmond,Michel O. Steinmetz,Imre Berger +12 more
TL;DR: Acembl is introduced, a versatile and automatable system for protein-complex expression in Escherichia coli that uses recombineering to facilitate multigene assembly and diversification.
Journal ArticleDOI
Centriolar CPAP/SAS-4 Imparts Slow Processive Microtubule Growth
Ashwani Sharma,Amol Aher,Nicola J. Dynes,Daniel Frey,Eugene A. Katrukha,Rolf Jaussi,Ilya Grigoriev,Marie Croisier,Richard A. Kammerer,Anna Akhmanova,Pierre Gönczy,Michel O. Steinmetz +11 more
TL;DR: This work brings together crystallographic, biophysical, and reconstitution assays to demonstrate that the human centriolar protein CPAP binds and “caps” microtubule plus ends by associating with a site of β-tubulin engaged in longitudinal tubulin- Tubulin interactions.